Published in World J Surg Oncol on January 25, 2016
CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol (2003) 3.39
Homeobox gene expression in the intestinal epithelium of adult mice. J Biol Chem (1991) 2.08
Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Br J Cancer (1984) 1.56
CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites. Arch Pathol Lab Med (2005) 1.13
The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody. Diagn Pathol (2012) 1.10
Epithelial tumors metastatic to the uterine cervix. A study of 33 cases and review of the literature. Cancer (1986) 1.01
Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2. Int J Gynecol Pathol (2008) 1.00
Metastatic carcinomas in the cervix mimicking primary cervical adenocarcinoma and adenocarcinoma in situ: report of a series of cases. Am J Surg Pathol (2010) 0.91
Tumor antigens CA 19.9, CA 125, and CEA in carcinoma of the uterine cervix. Gynecol Oncol (1995) 0.90
Comprehensive evaluation of CDX2 in invasive cervical adenocarcinomas: immunopositivity in the absence of overt colorectal morphology. Am J Surg Pathol (2008) 0.86
Uterine cervix metastasis from rectal carcinoma: a case report and a review of the literature. Jpn J Clin Oncol (1999) 0.86
Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix: an investigation using Cdx-2 and a limited immunohistochemical panel. Arch Pathol Lab Med (2003) 0.81
Increasing incidence of cecal and sigmoid carcinoma. Data from the Connecticut Tumor Registry. Cancer (1990) 0.79
Adenocarcinoma of the cervix: a regional retrospective study. Eur J Gynaecol Oncol (1997) 0.79
Solitary uterine metastasis of invasive lobular carcinoma after adjuvant endocrine therapy: a case report. J Med Case Rep (2015) 0.83